LRN vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

LRN

45.8
AI Score
VS
LRN Wins

UTI

38.6
AI Score

Investment Advisor Scores

LRN

46score
Recommendation
HOLD

UTI

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric LRN UTI Winner
Forward P/E 8.7642 30.2115 LRN
PEG Ratio 0.4383 2.0124 LRN
Revenue Growth 3.0% 7.2% UTI
Earnings Growth 3.6% -78.9% LRN
Tradestie Score 45.8/100 38.6/100 LRN
Profit Margin 13.2% 3.9% LRN
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY LRN

Relative Price Performance (Last 90 Days)

LRN 1M: -7.1% · 3M: -7.8% UTI 1M: +11.3% · 3M: -11.0%

Current Technical Phase

LRN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.6 · Price: $77.12

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.8 · Price: $23.00

Fundamentals Snapshot

Metric LRN UTI
Market Cap — —
Forward P/E 8.8 31.3
Trailing P/E 10.6 38.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.6%
Operating Margin 0.1% 0.0%
EPS 7.25 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LRN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.